09:01 AM EDT, 06/17/2024 (MT Newswires) -- Adam S Grossman, Director, President,CEO, and Interim CFO, on June 14, 2024, sold 570,000 shares in Adma Biologics ( ADMA ) for $2,548,580. Following the Form 4 filing with the SEC, Grossman has control over a total of 3,805,858 shares of the company, with 2,081,475 shares held directly and 1,724,383 shares controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1368514/000114036124030232/xslF345X03/form4.xml

Price: 10.59, Change: -0.04, Percent Change: -0.38